INDIANAPOLIS, US: Vertellus, a leading producer of specialty chemicals for the life sciences sector and other industrial applications, has signed a definitive agreement to acquire the Sodium Borohydride (SBH) business, including associated assets, from The Dow Chemical Company. Vertellus is a portfolio company of Chicago-based private equity firm Wind Point Partners.
The SBH Business is the leading manufacturer of sodium borohydride used in the synthesis of fine chemicals such as pharmaceutical ingredients and agrochemicals. Sodium borohydride is predominantly used as a critical synthesis and process aid in the production of a wide variety of active pharmaceutical ingredients including high growth antiretrovirals for the treatment of HIV/AIDS. It is also used in bleaching applications, such as mechanical wood pulping for newspaper and tissue production.
The acquisition accelerates Vertellus’ strategy to expand its product offerings in the life science sector through both organic growth and strategic acquisitions. Revenues from life science applications represent more than 65 per cent of the company’s total revenue, and Vertellus expects the acquisition will significantly increase its ability to provide tailored solutions to the pharmaceutical and agriculture sector.
“Vertellus is impressed with the SBH Business’ market leading position in the supply of processing aids to fine chemical customers, specifically pharmaceutical and agrochemical manufacturers. We are excited about the opportunity to serve the high growth synthesis segment from the SBH Business’ world class manufacturing facility in Elma, Washington,” said Rich Preziotti, CEO, Vertellus.
© Worldofchemicals News